These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27225192)

  • 41. DNA repair system and renal cell carcinoma prognosis: under the influence of NBS1.
    Rosinha A; Assis J; Dias F; Nogueira A; Pereira D; Maurício J; Teixeira AL; Medeiros R
    Med Oncol; 2015 Nov; 32(11):255. PubMed ID: 26493193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of IL-4 -590 T>C polymorphism and risk of renal cell carcinoma in a Chinese population.
    Zhu J; Ju X; Yan F; Qin C; Wang M; Ding Q; Zhang Z; Yin C
    Int J Immunogenet; 2010 Dec; 37(6):459-65. PubMed ID: 20618516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The T309G murine double minute 2 gene polymorphism is an independent prognostic factor for patients with renal cell carcinoma.
    de Martino M; Taus C; Wessely IS; Lucca I; Hofbauer SL; Haitel A; Shariat SF; Klatte T
    DNA Cell Biol; 2015 Feb; 34(2):107-12. PubMed ID: 25415135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concomitance of Polymorphisms in Glutathione Transferase Omega Genes Is Associated with Risk of Clear Cell Renal Cell Carcinoma.
    Radic TM; Coric VM; Pljesa-Ercegovac MS; Basta-Jovanovic GM; Radojevic-Skodric SM; Dragicevic DP; Matic MG; Bogdanovic LM; Dzamic ZM; Simic TP; Savic-Radojevic AR
    Tohoku J Exp Med; 2018 Sep; 246(1):35-44. PubMed ID: 30224590
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk.
    Shu X; Lin J; Wood CG; Tannir NM; Wu X
    J Natl Cancer Inst; 2013 Mar; 105(6):424-32. PubMed ID: 23378641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma.
    Parker AS; Cheville JC; Lohse CM; Igel T; Leibovich BC; Blute ML
    Urology; 2005 Jun; 65(6):1090-5. PubMed ID: 15893810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional variants in the low-density lipoprotein receptor gene are associated with clear cell renal cell carcinoma susceptibility.
    Zhang GM; Wang MY; Liu YN; Zhu Y; Wan FN; Wei QY; Ye DW
    Carcinogenesis; 2017 Dec; 38(12):1241-1248. PubMed ID: 29029037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways.
    Mitsui Y; Hirata H; Arichi N; Hiraki M; Yasumoto H; Chang I; Fukuhara S; Yamamura S; Shahryari V; Deng G; Saini S; Majid S; Dahiya R; Tanaka Y; Shiina H
    Oncotarget; 2015 Apr; 6(11):9577-91. PubMed ID: 25797254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA is associated with renal cell carcinoma outcome.
    Bai Y; Guo Z; Xu J; Liu S; Zhang J; Cui L; Zhang H; Zhang S
    Mitochondrial DNA; 2015 Apr; 26(2):224-6. PubMed ID: 24021012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leptin receptor gene (A/G) polymorphism rs1137101 and renal cell carcinoma.
    Abdu Allah AM; El-Hefnway SM; Alhanafy AM; Zahran AM; Kasem HE
    Mol Cell Biochem; 2018 Nov; 448(1-2):137-144. PubMed ID: 29453609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinoma.
    Ajaz S; Khaliq S; Abid A; Hassan AS; Hashmi A; Sultan G; Mohsin R; Mubarrak M; Naqvi SA; Rizvi SA; Mehdi SQ
    Genet Test Mol Biomarkers; 2011 Sep; 15(9):653-7. PubMed ID: 21491998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal cell carcinoma risk is associated with the interactions of APOE, VHL and MTHFR gene polymorphisms.
    Lv C; Bai Z; Liu Z; Luo P; Zhang J
    Int J Clin Exp Pathol; 2015; 8(5):5781-6. PubMed ID: 26191297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinoma.
    Chu H; Wang M; Yan F; Zhong D; Shi D; Ma L; Pan X; Qin C; Yin C; Zhang Z
    Ann Oncol; 2012 Aug; 23(8):2114-2121. PubMed ID: 22317767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of 3' nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population.
    Partyka A; Tupikowski K; Kolodziej A; Zdrojowy R; Halon A; Malkiewicz B; Dembowski J; Frydecka I; Karabon L
    Urol Oncol; 2016 Sep; 34(9):419.e13-9. PubMed ID: 27234378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polymorphism in protein tyrosine phosphatase receptor delta is associated with the risk of clear cell renal cell carcinoma.
    Du Y; Su T; Tan X; Li X; Xie J; Wang G; Shen J; Hou J; Cao G
    Gene; 2013 Jan; 512(1):64-9. PubMed ID: 23069849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
    Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High APOBEC3B expression is a predictor of recurrence in patients with low-risk clear cell renal cell carcinoma.
    Xu L; Chang Y; An H; Zhu Y; Yang Y; Xu J
    Urol Oncol; 2015 Aug; 33(8):340.e1-8. PubMed ID: 26051357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of caveolin-1 genotypes with renal cell carcinoma risk in Taiwan.
    Chang WS; Tsai CW; Wang SM; Wang SW; Wu HC; Ji HX; Lin CH; Wang ZH; Chou JC; Bau DT; Wang PS
    Chin J Physiol; 2014 Aug; 57(4):220-6. PubMed ID: 25246063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A four-gene signature predicts survival in clear-cell renal-cell carcinoma.
    Dai J; Lu Y; Wang J; Yang L; Han Y; Wang Y; Yan D; Ruan Q; Wang S
    Oncotarget; 2016 Dec; 7(50):82712-82726. PubMed ID: 27779101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control study.
    Shen BL; Qu QS; Miao SZ; Zhang YX
    Genet Mol Res; 2015 Sep; 14(3):11119-25. PubMed ID: 26400342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.